Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment

Detalhes bibliográficos
Autor(a) principal: Bhatt, Nilesh Balbhadra
Data de Publicação: 2014
Outros Autores: Barau, Caroline, Amin, Alexandre, Baudin, Elisabeth, Meggi, Bindiya, Silva, Carlota, Furlan, Valerie, Grinsztejn, Beatriz, Tran, Aurelie Barrail, Bonnet, Maryline, Taburet, Anne Marie
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/10578
Resumo: Agence Nationale de Recherches sur le Sida et les Hépatites Virales
id CRUZ_6e6582f140fc14d7943fca60d47b0dbb
oai_identifier_str oai:www.arca.fiocruz.br:icict/10578
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Bhatt, Nilesh BalbhadraBarau, CarolineAmin, AlexandreBaudin, ElisabethMeggi, BindiyaSilva, CarlotaFurlan, ValerieGrinsztejn, BeatrizTran, Aurelie BarrailBonnet, MarylineTaburet, Anne Marie2015-05-28T17:04:16Z2015-05-28T17:04:16Z2014BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014.0066-4804https://www.arca.fiocruz.br/handle/icict/1057810.1128/AAC.02379-131098-6596Agence Nationale de Recherches sur le Sida et les Hépatites ViralesFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Ministério da Saúde. Instituto Nacional de Saúde. Maputo, MozambiqueBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceEpicentre. Paris, PAR, FranceMinistério da Saúde. Instituto Nacional de Saúde. Maputo, MozambiqueEpicentre. Paris, PAR, FranceBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, BrasilBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France / University Paris Sud. Faculty of Pharmacy. Paris, FranceEpicentre. Paris, PAR, FranceBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceengAmerican Society for MicrobiologyPharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatmentinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleTuberculosisHIVRifampinIsoniazidTuberculoseHIVRifampinaIsoniazidainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82352https://www.arca.fiocruz.br/bitstream/icict/10578/1/license.txtafbdf7d7a9bcf771a1cc7edf5f618413MD51ORIGINALPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdfPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdfapplication/pdf621835https://www.arca.fiocruz.br/bitstream/icict/10578/2/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdfcadfb184f2cb879bef44dd91bc027a8fMD52TEXTPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdf.txtPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdf.txtExtracted texttext/plain53606https://www.arca.fiocruz.br/bitstream/icict/10578/3/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdf.txt47c9c1efe31cc227787e1bee188497bbMD53icict/105782023-06-15 16:17:42.157oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-06-15T19:17:42Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
title Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
spellingShingle Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
Bhatt, Nilesh Balbhadra
Tuberculosis
HIV
Rifampin
Isoniazid
Tuberculose
HIV
Rifampina
Isoniazida
title_short Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
title_full Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
title_fullStr Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
title_full_unstemmed Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
title_sort Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
author Bhatt, Nilesh Balbhadra
author_facet Bhatt, Nilesh Balbhadra
Barau, Caroline
Amin, Alexandre
Baudin, Elisabeth
Meggi, Bindiya
Silva, Carlota
Furlan, Valerie
Grinsztejn, Beatriz
Tran, Aurelie Barrail
Bonnet, Maryline
Taburet, Anne Marie
author_role author
author2 Barau, Caroline
Amin, Alexandre
Baudin, Elisabeth
Meggi, Bindiya
Silva, Carlota
Furlan, Valerie
Grinsztejn, Beatriz
Tran, Aurelie Barrail
Bonnet, Maryline
Taburet, Anne Marie
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bhatt, Nilesh Balbhadra
Barau, Caroline
Amin, Alexandre
Baudin, Elisabeth
Meggi, Bindiya
Silva, Carlota
Furlan, Valerie
Grinsztejn, Beatriz
Tran, Aurelie Barrail
Bonnet, Maryline
Taburet, Anne Marie
dc.subject.en.pt_BR.fl_str_mv Tuberculosis
HIV
Rifampin
Isoniazid
topic Tuberculosis
HIV
Rifampin
Isoniazid
Tuberculose
HIV
Rifampina
Isoniazida
dc.subject.decs.pt_BR.fl_str_mv Tuberculose
HIV
Rifampina
Isoniazida
description Agence Nationale de Recherches sur le Sida et les Hépatites Virales
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2015-05-28T17:04:16Z
dc.date.available.fl_str_mv 2015-05-28T17:04:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/10578
dc.identifier.issn.none.fl_str_mv 0066-4804
dc.identifier.doi.none.fl_str_mv 10.1128/AAC.02379-13
dc.identifier.eissn.none.fl_str_mv 1098-6596
identifier_str_mv BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014.
0066-4804
10.1128/AAC.02379-13
1098-6596
url https://www.arca.fiocruz.br/handle/icict/10578
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/10578/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/10578/2/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdf
https://www.arca.fiocruz.br/bitstream/icict/10578/3/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdf.txt
bitstream.checksum.fl_str_mv afbdf7d7a9bcf771a1cc7edf5f618413
cadfb184f2cb879bef44dd91bc027a8f
47c9c1efe31cc227787e1bee188497bb
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324902213713920

Registros relacionados